Clinical Trial Update: PsA Secukinumab XCT Structural Progression Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for secukinumab in psoriatic arthritis completed, reporting structural progression study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Psoriatic Arthritis | Phase 4 | Status: COMPLETED